Humachag, Larabel .

HRN: 17-60-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2026
CEFAZOLIN 1GM (VIAL)
05/27/2026
05/27/2026
IV
2g
PTOR
Pre Op Prophylaxis
Checking Initial Appropriateness 
05/27/2026
CEFAZOLIN 1GM (VIAL)
05/27/2026
05/29/2026
IV
2gms
Q8hrs X 5 Doses
S/P Primary LTCS With Intracesarean IUD
Checking Initial Appropriateness 
05/27/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2026
05/29/2026
IV
500mg
Q8hrs X 6 Doses
S/P Primary LTCS With Intracesarean IUD
Checking Initial Appropriateness 
05/28/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/28/2026
05/28/2026
IV
900mg
Q8hr X 3 Doses
Sp PLTCS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: